Clinical Trials Browser

Phase 2 × Digestive System Neoplasms × anlotinib × Clear all

NCT05262335 2023-11-28

ALTER-G-001

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms

NCT04207463 2020-06-17

A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

Phase 2 Unknown

EndocrineGastrointestinalNET

Digestive System Neoplasms, Neuroendocrine Tumors